A new study published in the Chinese Journal of Pathology concluded that testing for the expression of the BAP1 protein increases the accuracy of mesothelioma diagnosis to 93%. Pleural mesothelioma is notoriously difficult to diagnose because of how many different diseases it mimics. Studies have found that the tumor suppressing protein BAP1 is found in 70% to 90% of pleural mesothelioma patients but only in 20% of non-mesothelioma patients.
Zy Guo, author of the report concluded that, “It is therefore recommended that BAP1 can be used in conjunction with other immunohistochemical markers to improve the diagnostic accuracy of malignant mesothelioma.” The hope is that BAP1 can help provide a more accurate diagnosis earlier which is critical to extending mesothelioma survival rates and increasing standards of living for patients.
The Paul Law Firm advocates for victims of asbestos-related diseases. If you or a loved one is suffering from mesothelioma, call the Paul Law Firm. With over 2.5 billion dollars collected for victims of asbestos exposure, we have the knowledge and the experience to fight for you. We also understand that fighting doesn’t just happen in the courtroom. It also happens in a lab where we are fighting for a cure. Check out the Mesothelioma Research Foundation of America here.
Call us today at 1-855 88 LEGAL (885-3425) or contact us online to discuss your case with one of our experienced mesothelioma lawyers
